Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2010
10/14/2010US20100261747 Novel pharmaceutical compositions and methods of preparation and use
10/14/2010US20100261716 Indazole-carboxamide compounds as 5-ht4 receptor agonists
10/14/2010US20100261676 Use of an Endogenous Ligand for Peroxisome Proliferator Activated Receptor Alpha to Treat Liver Disorders
10/14/2010US20100261617 Gene expression signature for the prognosis, diagnosis, and therapy of prostate cancer and uses thereof
10/14/2010US20100261612 Purification and Concentration of Proteins and DNA from a Complex Sample Using Isotachophoresis and a Device to Perform the Purification
10/14/2010US20100261293 Diagnostic detection device
10/14/2010US20100261292 Methods for Conducting Assays
10/14/2010US20100261291 Nucleic acids specifically binding bioactive ghrelin
10/14/2010US20100261285 Tagged-fragment map assembly
10/14/2010US20100261284 Using gdf 15 to assess patients presenting to emergency units
10/14/2010US20100261283 Surfactant proteins b and d for differential diagnosis of dyspnea
10/14/2010US20100261282 Method of evaluating IGT, IGT-evaluating apparatus, IGT-evaluating method, IGT--evaluating system, IGT-evaluating program, recording medium, and method of searching for prophylactic/ameliorating substance for IGT
10/14/2010US20100261281 Analytical technique for measuring bound glycerides in a biodiesel composition
10/14/2010US20100261280 Biological and chemical monitoring
10/14/2010US20100261279 Mass spectrum-based identification and quantitation of proteins and peptides
10/14/2010US20100261264 Test apparatus
10/14/2010US20100261224 Discovery and validation of cancer biomarkers using a protein analysis methodology to analyze specimens
10/14/2010US20100261221 Method to predict or diagnose a gastrointestinal disorder or disease
10/14/2010US20100261212 Kinetics of molecular recognition mediated nanoparticle self-assembly
10/14/2010US20100261210 Compositions and methods for diagnosing and treating prostate cancer
10/14/2010US20100261209 Biomarkers for liver diseases and method for using the same
10/14/2010US20100261208 Elispot method having two filter systems
10/14/2010US20100261207 Neutrokine-alpha and neutrokine-alpha splice variant
10/14/2010US20100261206 Peptide fragments reacting specifically with antibodies against highly pathogenic newcastle disease virus and uses thereof
10/14/2010US20100261205 Microchips, kits, and methods for immunoassays
10/14/2010US20100261204 Composite Profiles of Cell Antigens and Target Signal Transduction Proteins for Analysis and Clinical Management of Hematologic Cancers
10/14/2010US20100261203 Methods and kits for screening transplant recipients and candidates
10/14/2010US20100261202 Method for efficient production of monocyte-derived multipotent cell (momc)
10/14/2010US20100261201 Assay for monitoring activity of frizzled receptors
10/14/2010US20100261200 Glycoprotein VI and Uses Thereof
10/14/2010US20100261199 Assay for the detection of phosphorylated PTH
10/14/2010US20100261198 Methods of detection of factor xia and tissue factor
10/14/2010US20100261197 Method, System, and Compositions for Cell Counting and Analysis
10/14/2010US20100261196 Methods of identifying small molecules for renewals, survival and migration of cardiac progenitors
10/14/2010US20100261195 Rapid antemortem detection of infectious agents
10/14/2010US20100261194 Neutrokine-alpha antibodies and methods of use thereof
10/14/2010US20100261193 Valve Structure for Consistent Valve Operation of a Miniaturized Fluid Delivery and Analysis System
10/14/2010US20100261182 Ppm1e proteins and nucleic acids as targets for neurodegenerative diseases
10/14/2010US20100261181 Labeling and detection of nucleic acids
10/14/2010US20100261178 High Throughput Assays for Inhibitors and Activators of PAQR Receptors
10/14/2010US20100261176 Methods of Tissue-Based Diagnosis
10/14/2010US20100261174 Determination of 5-ASA efficacy in CRC prevention and/or treatment by gene expression analysis
10/14/2010US20100261169 Novel nucleotide and amino acid sequences, and methods of use thereof for diagnosis
10/14/2010US20100261167 In vivo screen using chemical inducers of dimerization
10/14/2010US20100261164 Diagnostic detection of nucleic acids
10/14/2010US20100261160 Methods of screening for modulators of cell proliferation and methods of diagnosing cell proliferation states
10/14/2010US20100261159 Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof
10/14/2010US20100261060 Lithium iron phosphate having olivine structure and method for analyzing the same
10/14/2010US20100260984 Microdevices containing photorecognizable coding patterns and methods of using and producing the same
10/14/2010US20100260903 Device for the qualification of cooking oils, and methods
10/14/2010US20100260828 Modulation of Platelet Aggregation
10/14/2010US20100260827 Methods of diagnosing, preventing and treating cancer metastasis
10/14/2010US20100260783 Antibody Specific Binding to A Beta Oligomer and the Use
10/14/2010US20100260776 Therapeutic method for reducing angiogenesis
10/14/2010US20100260771 Method for Diagnosing the Metabolic Syndrome (MS)
10/14/2010US20100260769 Endosialin binding molecules
10/14/2010US20100260768 Anti mif antibodies
10/14/2010US20100260764 Compositions and methods for inhibiting squamous cell carcinoma
10/14/2010US20100260762 De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
10/14/2010US20100260758 In vivo modulation of neuronal transport
10/14/2010US20100260756 Antibodies and related molecules that bind to 161p2f10b proteins
10/14/2010US20100260751 Methods and Structural Conformations of Antibody Preparations with Increased Resistance to Proteases
10/14/2010US20100260748 ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE
10/14/2010US20100260747 Use of Tetrahydrobiopterin as a Marker and a Therapeutic Agent for Fabry Disease
10/14/2010US20100260745 Methods of using and constructing nanosensor platforms
10/14/2010US20100260739 Mirac Proteins
10/14/2010US20100260738 Uses and methods relating to ndr kinase expression and/or activity
10/14/2010US20100260736 Egr1 modulators for the treatment of alopecia
10/14/2010US20100260733 Novel anti aging agents and methods to identify them
10/14/2010US20100260724 Method for measuring the plasmine activity of microparticles present in a sample of a biological fluid and use thereof
10/14/2010US20100260717 Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection
10/14/2010US20100260707 Antigen associated with rheumatoid arthritis
10/14/2010US20100260705 Products for altering il-33 activity and methods thereof
10/14/2010US20100260686 Nanoparticles for brain tumor imaging
10/14/2010US20100260682 Compounds and methods of use thereof for assaying lysophospholipase D activity
10/14/2010US20100260681 Adrenocorticotropic hormone analogs and related methods
10/14/2010US20100260679 Method and apparatus for detecting and regulating vascular endothelial growth factor (vegf) by forming a homeostatic loop employing a half-antibody biosensor
10/14/2010US20100260678 Anti-igf-i receptor antibodies
10/14/2010US20100260672 Peptides that specifically bind hgf receptor (cmet) and uses thereof
10/14/2010US20100260667 Vimentin Directed Diagnostics And Therapeutics For Multidrug Resistant Neoplastic Disease
10/14/2010US20100260642 laminar flow devices to position a fluid flow over one or more discrete sensing areas within a flow cell; for improved sample delivery techniques within the context of flow cell-based detection instruments; surface plasmon resonance
10/14/2010US20100259747 Sample detector and measurement device equipped with the same
10/14/2010US20100259254 Sensor device for target particles in a sample
10/14/2010US20100258452 Electrode for electrochemical measurement apparatus and electrode for biosensor
10/14/2010US20100258438 Biosensor
10/14/2010US20100258233 Ceramic substrate, method of manufacturing ceramic substrate, and method of manufacturing power module substrate
10/14/2010DE202009014955U1 Wirkstofffreisetzungsvorrichtung zur Ermittlung des Freisetzungsverhaltens peroraler Arzneiformen Drug release device for determining the release characteristics of peroral dosage forms
10/14/2010DE202009011492U1 Messvorrichtung für Fluide Measuring device for fluids
10/14/2010DE112008003242T5 Temperaturhaltesystem für einen Sensor Temperature maintenance system for a sensor
10/14/2010DE102009024673A1 Modifikation von Schichtsilikaten für die Lumineszenzaktivierung Modification of layered silicates for Lumineszenzaktivierung
10/14/2010DE102009024229B3 Indication device for automatic determination of individual incretin sensitivity indexes of test person during treatment of non-insulin dependent diabetic mellitus, has output module providing data signal as result of simulation strategy
10/14/2010DE102009016712A1 Einweg-Mikrofluidik-Testkassette zur Bioassay von Analyten Disposable microfluidic test cassette for bioassay of analytes
10/14/2010DE102009016642A1 Verschlussvorrichtung, Gehäuseteil eines Schmiermittelbehälters, Diagnosesystem und Diagnoseverfahren zur Überwachung des Betriebszustands eines Schmiermittels in dem Gehäuseteil Closure device, the container housing part of a lubricant, diagnostics system and diagnostic methods for monitoring the operating state of a lubricant into the housing part
10/14/2010DE102009015740A1 Molded mass, where the surface of the molded mass is so provided or modified that an organic material is separated from aqueous saliva and bounded on surface, useful for detecting pathogens, preferably bacteria and viruses in mouth
10/14/2010DE102009015114A1 Vorrichtung nach Art einer elektrochemischen Kamera sowie Verfahren zur Herstellung und Verwendung der Vorrichtung Device according to the manner of a camera as well as electrochemical methods of making and using the apparatus
10/14/2010CA2758152A1 A strip-shaped detector detecting an analyte in a liquid sample and detection method
10/14/2010CA2758065A1 Device and method for the verification and quantitative analysis of analytes, particularly mycotoxins
10/14/2010CA2757941A1 Therapeutic agent for diseases in which neoplastic proliferation of plasma cells occurs
10/14/2010CA2757927A1 Methods of predicting cancer risk using gene expression in premalignant tissue
10/14/2010CA2757659A1 Biomarkers for monitoring treatment of neuropsychiatric diseases